{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:40:07Z","timestamp":1777938007401,"version":"3.51.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Toxicology laboratories commonly employ immunoassay methodologies to perform an initial drug screen on urine specimens to direct confirmatory testing. Due to limitations of immunoassay testing and the need to screen for a broader range of drugs with lower limits of detection at a lower cost, mass spectrometry screening techniques have gained favor in the toxicology field. A liquid chromatography\u2013tandem mass spectrometry (LC-MS-MS) urine screening panel was developed and validated for 52 drugs and metabolites. A simple dilute-and-shoot with enzymatic hydrolysis technique was utilized to prepare the urine specimens for analysis. Limit of detection, interference, ionization suppression\/enhancement, carryover and stability of processed specimens were assessed during validation. To evaluate the toxicological results obtained from utilizing the LC-MS-MS in comparison with the laboratory\u2019s current enzyme-linked immunosorbent assay (ELISA) panel, 100 authentic urine specimens from suspected driving under the influence and drug-facilitated crime cases were analyzed using both methodologies and the results were compared. In addition, the cost of each methodology was evaluated and compared. The validated LC-MS-MS method had limits of detection that were equal to or lower than the concentrations validated for ELISA cutoffs, had fewer exogenous interferences, and the cost of screening per specimen was reduced by ~70% when compared to ELISA. Comparing the toxicology results of forensic urine specimens demonstrated that by only using ELISA, the laboratory was unable to detect benzoylecgonine in 26%, lorazepam in 33% and oxymorphone in 60% of the positive specimens. Additional analytes detected using the LC-MS-MS method were zolpidem and\/or metabolite, gabapentin, tramadol and metabolite, methadone and metabolite, meprobamate and phentermine. The results of the validation, the toxicological result comparison and the cost comparison showed that the LC-MS-MS screening method is a simple, sensitive and cost-effective alternative to ELISA screening methods for urine specimens.<\/jats:p>","DOI":"10.1093\/jat\/bkz066","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:09:25Z","timestamp":1563217765000},"page":"734-745","source":"Crossref","is-referenced-by-count":39,"title":["LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens"],"prefix":"10.1093","volume":"43","author":[{"given":"Kristin W","family":"Kahl","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Rosenstiel Medical Science Building (RMSB), 1600 NM 10th Avenue, 7th Floor Suite 7020 (R-5), Miami, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua Z","family":"Seither","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Rosenstiel Medical Science Building (RMSB), 1600 NM 10th Avenue, 7th Floor Suite 7020 (R-5), Miami, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J","family":"Reidy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Rosenstiel Medical Science Building (RMSB), 1600 NM 10th Avenue, 7th Floor Suite 7020 (R-5), Miami, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"2019122605273856300_ref1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5858\/134.5.735","article-title":"Interpretation and utility of drug of abuse immunoassay: lessons from drug testing surveys","volume":"134","author":"Melanson","year":"2010","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"2019122605273856300_ref2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jat\/33.3.177","article-title":"Evaluation of a new ELISA kit for the detection of benzodiazepines in meconium","volume":"33","author":"Marin","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2146\/ajhp090477","article-title":"Commonly prescribed medication and potential false-positive drug screens","volume":"67","author":"Brahm","year":"2010","journal-title":"American Journal of Health System-Pharmacy"},{"key":"2019122605273856300_ref4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0196-0644(05)80129-5","article-title":"Doxepin causing false-positive urine test for amphetamine","volume":"22","author":"Merigian","year":"1993","journal-title":"Annals of Emergency Medicine"},{"key":"2019122605273856300_ref5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3476(95)70143-5","article-title":"Benzathine as a cause for false-positive test result for amphetamines","volume":"127","author":"Berthier","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"2019122605273856300_ref6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinchem\/38.4.611","article-title":"Metabolites of chlorpromazine and brompheniramine may cause false-positive urine amphetamine results with monoclonal EMIT d.a.u. immunoassay [Letter]","volume":"38","author":"Olsen","year":"1992","journal-title":"Clinical Chemistry"},{"key":"2019122605273856300_ref7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/FTD.0b013e3182126d08","article-title":"Cross reactivity of bupropion metabolite with enzyme-linked immunosorbent assay designed to detect amphetamine in urine","volume":"33","author":"Reidy","year":"2011","journal-title":"Therapeutic Drug Monitoring"},{"key":"2019122605273856300_ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jat\/bky060","article-title":"Validation and cross-reactivity data for fentanyl analogs with immunalysis fentanyl ELISA","volume":"43","author":"Guerrieri","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref9","first-page":"313","article-title":"Validation of the Neogen fentanyl ELISA kit for blood and urine","volume":"41","author":"Tiscione","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jat\/bkx082","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2017 update","volume":"42","author":"Logan","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref11","author":"Society of Forensic Toxicologists-Drug Facilitated Crimes Committee","year":"2017"},{"key":"2019122605273856300_ref12","first-page":"17","article-title":"A novel \u201cdilute-and-shoot\u201d liquid chromatography\u2013tandem mass spectrometry method for the screening of antihypertensive drugs in urine","volume":"40","author":"Lawson","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref13","first-page":"28","article-title":"Determination of drugs in plasma samples by high-performance liquid chromatography\u2013tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients","volume":"40","author":"Domingues","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2019122605273856300_ref14","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2009"},{"key":"2019122605273856300_ref15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology (SWGTOX)","year":"2013","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/43\/9\/734\/31616844\/bkz066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/43\/9\/734\/31616844\/bkz066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T22:59:19Z","timestamp":1663973959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/43\/9\/734\/5550874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,19]]},"published-print":{"date-parts":[[2019,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkz066","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,8,19]]}}}